Blood pressure assessment, control, and monitoring should be mandatory components of clinical management in children with NAFLD, because patients with non-alcoholic steatohepatitis (NASH) and/or obesity are at higher cardiovascular risk due to peripheral insulin resistance, oxidative stress, and systemic inflammation [24]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.